Cardiomyopathy, Hypertrophic

"Cardiomyopathy, Hypertrophic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Descriptor ID	D002312
MeSH Number(s)	C14.280.238.100 C14.280.484.150.070.160
Concept/Terms	Cardiomyopathy, Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathies, Hypertrophic Hypertrophic Cardiomyopathies Hypertrophic Cardiomyopathy Cardiomyopathy, Hypertrophic Obstructive Cardiomyopathies, Hypertrophic Obstructive Hypertrophic Obstructive Cardiomyopathies Hypertrophic Obstructive Cardiomyopathy Obstructive Cardiomyopathies, Hypertrophic Obstructive Cardiomyopathy, Hypertrophic

Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Cardiomyopathies [C14.280.238]
Cardiomyopathy, Hypertrophic [C14.280.238.100]
Heart Valve Diseases [C14.280.484]
Aortic Valve Stenosis [C14.280.484.150]
Aortic Stenosis, Subvalvular [C14.280.484.150.070]
Cardiomyopathy, Hypertrophic [C14.280.484.150.070.160]

Below are MeSH descriptors whose meaning is related to "Cardiomyopathy, Hypertrophic".

Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic".

Cardiomyopathy, Hypertrophic
Cardiomyopathy, Hypertrophic, Familial

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic" was a major or minor topic of these publications.

Bar chart showing 54 publications over 25 distinct years, with a maximum of 5 publications in 2009 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	2	0	2
1997	2	1	3
1998	0	1	1
2000	1	0	1
2002	0	1	1
2005	1	0	1
2007	0	1	1
2008	2	0	2
2009	3	2	5
2010	1	0	1
2011	1	0	1
2012	2	0	2
2013	1	0	1
2014	2	1	3
2015	3	0	3
2016	1	0	1
2017	2	0	2
2018	2	0	2
2019	1	2	3
2020	5	0	5
2021	4	0	4
2022	4	0	4
2023	2	0	2
2024	2	0	2

Below are the most recent publications written about "Cardiomyopathy, Hypertrophic" by people in Profiles.

Tahir UA, Kolm P, Kwong RY, Desai MY, Dolman SF, Deng S, Appelbaum E, Desvigne-Nickens P, DiMarco JP, Tiwari G, Friedrich MG, Zelaya-Portillo JH, Jerosch-Herold M, Kim DY, Maron MS, Piechnik SK, Schulz-Menger J, Watkins H, Weintraub WS, Neubauer S, Kramer CM, Jarolim P, Gerszten RE, Ho CY. Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy. Circ Heart Fail. 2024 Dec; 17(12):e011707.

View in: PubMed
Mazur M, Bhat G, Popjes E, Dowling R, Eisen HJ. Long-term post-transplantation outcomes in patients with hypertrophic cardiomyopathy: Single-center 35-year experience. Clin Transplant. 2024 Feb; 38(2):e15265.

View in: PubMed
Hermida U, Stojanovski D, Raman B, Ariga R, Young AA, Carapella V, Carr-White G, Lukaschuk E, Piechnik SK, Kramer CM, Desai MY, Weintraub WS, Neubauer S, Watkins H, Lamata P. Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy. Eur Heart J Cardiovasc Imaging. 2023 05 31; 24(6):807-818.

View in: PubMed
Aung N, Lopes LR, van Duijvenboden S, Harper AR, Goel A, Grace C, Ho CY, Weintraub WS, Kramer CM, Neubauer S, Watkins HC, Petersen SE, Munroe PB. Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy. Circ Genom Precis Med. 2023 02; 16(1):e003716.

View in: PubMed
Heydari B, Satriano A, Jerosch-Herold M, Kolm P, Kim DY, Cheng K, Choi YL, Antiochos P, White JA, Mahmod M, Chan K, Raman B, Desai MY, Ho CY, Dolman SF, Desvigne-Nickens P, Maron MS, Friedrich MG, Schulz-Menger J, Piechnik SK, Appelbaum E, Weintraub WS, Neubauer S, Kramer CM, Kwong RY. 3-Dimensional Strain Analysis of?Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry. JACC Cardiovasc Imaging. 2023 04; 16(4):478-491.

View in: PubMed
Sahota M, Saraskani SR, Xu H, Li L, Majeed AW, Hermida U, Neubauer S, Desai M, Weintraub W, Desvigne-Nickens P, Schulz-Menger J, Kwong RY, Kramer CM, Young AA, Lamata P. Machine learning evaluation of LV outflow obstruction in hypertrophic cardiomyopathy using three-chamber cardiovascular magnetic resonance. Int J Cardiovasc Imaging. 2022 Dec; 38(12):2695-2705.

View in: PubMed
Riaz M, Park J, Sewanan LR, Ren Y, Schwan J, Das SK, Pomianowski PT, Huang Y, Ellis MW, Luo J, Liu J, Song L, Chen IP, Qiu C, Yazawa M, Tellides G, Hwa J, Young LH, Yang L, Marboe CC, Jacoby DL, Campbell SG, Qyang Y. Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy. Circulation. 2022 04 19; 145(16):1238-1253.

View in: PubMed
O'Hara RP, Binka E, Prakosa A, Zimmerman SL, Cartoski MJ, Abraham MR, Lu DY, Boyle PM, Trayanova NA. Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy. Elife. 2022 01 25; 11.

View in: PubMed
Hegde SM, Lester SJ, Solomon SD, Michels M, Elliott PM, Nagueh SF, Choudhury L, Zemanek D, Zwas DR, Jacoby D, Wang A, Ho CY, Li W, Sehnert AJ, Olivotto I, Abraham TP. Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2021 12 21; 78(25):2518-2532.

View in: PubMed
Nedios S, Dinov B, Seew?ster T, Lindemann F, Richter S, Arya A, Dagres N, Husser D, Bollmann A, Hindricks G, M?ssigbrodt A. Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy. Sci Rep. 2021 06 14; 11(1):12411.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement